Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
2.265
-0.045 (-1.95%)
May 28, 2026, 3:41 PM EDT - Market open

BDTX Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
13013912114566193
Market Cap Growth
30.43%14.54%-16.47%121.29%-66.04%-83.30%
Enterprise Value
30.8525.2641.4335.91-31.9311.48
Last Close Price
2.272.432.142.811.805.33
PE Ratio
-6.23----
PS Ratio
-1.98----
PB Ratio
1.271.241.461.240.570.99
P/TBV Ratio
1.241.251.411.060.560.99
P/FCF Ratio
-4.69----
P/OCF Ratio
-4.69----
EV/Sales Ratio
-0.36----
EV/EBITDA Ratio
-2.18--0.35-
EV/EBIT Ratio
-2.02--0.34-
EV/FCF Ratio
-0.85--0.37-
Debt / Equity Ratio
0.140.130.230.190.220.14
Debt / EBITDA Ratio
-1.30----
Debt / FCF Ratio
-0.51----
Net Debt / Equity Ratio
-1.00-1.01-0.96-0.94-0.84-0.93
Net Debt / EBITDA Ratio
1.93-9.820.971.251.061.46
Net Debt / FCF Ratio
3.06-3.831.281.641.141.77
Asset Turnover
-0.530000
Quick Ratio
8.148.184.796.698.058.87
Current Ratio
8.468.424.926.828.379.12
Return on Equity (ROE)
-39.92%22.88%-69.67%-70.94%-57.07%-49.87%
Return on Assets (ROA)
-38.61%9.43%-56.03%-54.93%-45.96%-43.95%
Return on Invested Capital (ROIC)
8570.72%1181.88%-1430.69%-672.63%-572.29%-1733.34%
Return on Capital Employed (ROCE)
-43.37%10.92%-65.38%-61.78%-50.86%-47.03%
Earnings Yield
-16.05%----
FCF Yield
-21.33%----
Buyback Yield / Dilution
-0.91%-4.61%-25.19%-21.00%-0.38%-9.97%
Total Shareholder Return
-0.91%-4.61%-25.19%-21.00%-0.38%-9.97%
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q